908 DEVICES INC. Operating Income
908 DEVICES INC. (MASS) reported Operating Income of -$12.81 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-11
- 908 DEVICES INC. operating income (loss) for the quarter ending 2026-06-30 was -$12.81M.
- 908 DEVICES INC. operating income (loss) for the quarter ending 2026-03-31 was -$12.88M.
- 908 DEVICES INC. operating income (loss) for the quarter ending 2025-12-31 was $3.09M.
- 908 DEVICES INC. operating income (loss) for the quarter ending 2025-09-30 was -$16.32M.
- 908 DEVICES INC. operating income (loss) for fiscal 2025 was -$39.42M.
- 908 DEVICES INC. operating income (loss) for fiscal 2024 was -$57.39M.
- 908 DEVICES INC. operating income (loss) for fiscal 2023 was -$42.76M.
- 908 DEVICES INC. operating income (loss) for fiscal 2022 was -$35.38M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$12.81M 10-Q · filed 2026-08-11 | -$25.69M 10-Q · filed 2026-08-11 | -$22.60M derived: sum of 3 quarters · filed 2026-08-11 | -$38.92M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2026-03-31 | -$12.88M 10-Q · filed 2026-05-06 | -$9.79M derived: sum of 2 quarters · filed 2026-05-06 | -$26.12M derived: sum of 3 quarters · filed 2026-05-06 | -$41.28M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-12-31 | $3.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$13.23M derived: sum of 2 quarters · filed 2026-03-09 | -$28.39M derived: sum of 3 quarters · filed 2026-08-11 | -$39.42M 10-K · filed 2026-03-09 | ||||
| 2025-09-30 | -$16.32M 10-Q · filed 2025-11-10 | -$31.48M derived: sum of 2 quarters · filed 2026-08-11 | -$42.51M 10-Q · filed 2025-11-10 | -$59.26M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-06-30 | -$15.16M 10-Q · filed 2026-08-11 | -$26.19M 10-Q · filed 2026-08-11 | -$42.94M derived: sum of 3 quarters · filed 2026-08-11 | -$67.43M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-03-31 | -$11.03M 10-Q · filed 2026-05-06 | -$27.77M derived: sum of 2 quarters · filed 2026-05-06 | -$52.27M derived: sum of 3 quarters · filed 2026-05-06 | -$60.81M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | -$16.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$41.24M derived: sum of 2 quarters · filed 2026-03-09 | -$49.78M derived: sum of 3 quarters · filed 2026-03-09 | -$57.39M 10-K · filed 2026-03-09 | -$76.72M 10-K · filed 2025-03-07 | |||
| 2024-09-30 | -$24.49M 10-Q · filed 2025-11-10 | -$30.22M 10-Q · filed 2024-11-12 | -$33.03M derived: sum of 2 quarters · filed 2025-11-10 | -$40.64M 10-Q · filed 2025-11-10 | -$56.47M 10-Q · filed 2024-11-12 | -$50.36M derived: sum of 4 quarters · filed 2025-11-10 | ||
| 2024-06-30 | -$8.54M 10-Q · filed 2025-08-05 | -$13.56M 10-Q · filed 2024-08-06 | -$16.15M 10-Q · filed 2025-08-05 | -$26.25M 10-Q · filed 2024-08-06 | -$25.86M derived: sum of 3 quarters · filed 2025-08-05 | -$34.95M derived: sum of 4 quarters · filed 2025-08-05 | ||
| 2024-03-31 | -$7.61M 10-Q · filed 2025-05-13 | -$12.69M 10-Q · filed 2024-05-03 | -$17.32M derived: sum of 2 quarters · filed 2025-05-13 | -$26.41M derived: sum of 3 quarters · filed 2025-05-13 | -$37.35M derived: sum of 4 quarters · filed 2025-05-13 | |||
| 2023-12-31 | -$9.71M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | -$18.80M derived: sum of 2 quarters · filed 2025-03-07 | -$29.74M derived: sum of 3 quarters · filed 2025-03-07 | -$42.76M 10-K · filed 2025-03-07 | ||||
| 2023-09-30 | -$9.09M 10-Q · filed 2024-11-12 | -$20.03M derived: sum of 2 quarters · filed 2024-11-12 | -$33.05M 10-Q · filed 2024-11-12 | -$43.38M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | -$10.94M 10-Q · filed 2024-08-06 | -$23.96M 10-Q · filed 2024-08-06 | -$34.29M derived: sum of 3 quarters · filed 2024-08-06 | -$41.45M derived: sum of 4 quarters · filed 2024-08-06 | ||||
| 2023-03-31 | -$13.02M 10-Q · filed 2024-05-03 | -$23.36M derived: sum of 2 quarters · filed 2024-05-03 | -$30.51M derived: sum of 3 quarters · filed 2024-05-03 | -$38.88M derived: sum of 4 quarters · filed 2024-05-03 | ||||
| 2022-12-31 | -$10.34M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | -$17.49M derived: sum of 2 quarters · filed 2024-03-08 | -$25.86M derived: sum of 3 quarters · filed 2024-03-08 | -$35.38M 10-K · filed 2024-03-08 | ||||
| 2022-09-30 | -$7.15M 10-Q · filed 2023-11-07 | -$15.52M derived: sum of 2 quarters · filed 2023-11-07 | -$25.04M 10-Q · filed 2023-11-07 | -$28.57M derived: sum of 4 quarters · filed 2023-11-07 | ||||
| 2022-06-30 | -$8.37M 10-Q · filed 2023-08-08 | -$17.89M 10-Q · filed 2023-08-08 | -$21.42M derived: sum of 3 quarters · filed 2023-08-08 | -$26.69M derived: sum of 4 quarters · filed 2023-08-08 | ||||
| 2022-03-31 | -$9.52M 10-Q · filed 2023-05-09 | -$13.05M derived: sum of 2 quarters · filed 2023-05-09 | -$18.32M derived: sum of 3 quarters · filed 2023-05-09 | -$25.78M derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2021-12-31 | -$3.53M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | -$8.80M derived: sum of 2 quarters · filed 2023-03-15 | -$16.26M derived: sum of 3 quarters · filed 2023-03-15 | -$22.07M 10-K · filed 2023-03-15 | ||||
| 2021-09-30 | -$5.28M 10-Q · filed 2022-11-14 | -$12.73M derived: sum of 2 quarters · filed 2022-11-14 | -$18.54M 10-Q · filed 2022-11-14 | -$22.43M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | -$7.46M 10-Q · filed 2022-08-09 | -$13.27M 10-Q · filed 2022-08-09 | -$17.15M derived: sum of 3 quarters · filed 2022-08-09 | -$18.44M derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | -$5.81M 10-Q · filed 2022-05-10 | -$9.70M derived: sum of 2 quarters · filed 2022-05-10 | -$10.99M derived: sum of 3 quarters · filed 2022-05-10 | -$8.86M derived: sum of 4 quarters · filed 2022-05-10 | ||||
| 2020-12-31 | -$3.89M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | -$5.18M derived: sum of 2 quarters · filed 2022-03-11 | -$3.05M derived: sum of 3 quarters · filed 2022-03-11 | -$5.82M 10-K · filed 2022-03-11 | ||||
| 2020-09-30 | -$1.29M 10-Q · filed 2021-11-04 | $835.00K derived: sum of 2 quarters · filed 2021-11-04 | -$1.93M 10-Q · filed 2021-11-04 | |||||
| 2020-06-30 | $2.13M 10-Q · filed 2021-08-04 | -$636.00K 10-Q · filed 2021-08-04 | ||||||
| 2020-03-31 | -$2.76M 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |